RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
14.85
+0.29 (1.99%)
Apr 29, 2025, 2:22 PM EDT - Market open
RxSight Employees
RxSight had 498 employees as of December 31, 2024. The number of employees increased by 124 or 33.16% compared to the previous year.
Employees
498
Change (1Y)
124
Growth (1Y)
33.16%
Revenue / Employee
$280,978
Profits / Employee
-$55,131
Market Cap
603.21M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 498 | 124 | 33.16% |
Dec 31, 2023 | 374 | 82 | 28.08% |
Dec 31, 2022 | 292 | 71 | 32.13% |
Dec 31, 2021 | 221 | 50 | 29.24% |
Dec 31, 2020 | 171 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
RXST News
- 25 days ago - RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade) - Seeking Alpha
- 25 days ago - RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript) - Seeking Alpha
- 26 days ago - RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance - GlobeNewsWire
- 4 weeks ago - RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - RxSight, Inc. (RXST) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance - GlobeNewsWire
- 3 months ago - RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance - GlobeNewsWire
- 4 months ago - RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - GlobeNewsWire